Today: 1 July 2026
Browse Category

NASDAQ:MIRM 19 December 2025 - 4 May 2026

Mirum Stock Jumps After Volixibat Trial Win Puts First PSC Itch Drug Within Reach

Mirum Stock Jumps After Volixibat Trial Win Puts First PSC Itch Drug Within Reach

FOSTER CITY, California, May 4, 2026, 13:04 PDT Shares of Mirum Pharmaceuticals surged Monday, after the company announced its experimental therapy volixibat hit the primary endpoint in a Phase 2b study targeting primary sclerosing cholangitis, or PSC—a rare liver condition marked by scarring of the bile ducts and potential liver failure. The study zeroed in on cholestatic pruritus, the intense itching caused by impaired bile flow and notorious as one of PSC’s toughest symptoms.
4 May 2026
··
Mirum Pharmaceuticals (MIRM) Stock Jumps on New $68.5M TCGX Financing, Bluejay Deal Momentum, and a Fresh $140 Price Target

Mirum Pharmaceuticals (MIRM) Stock Jumps on New $68.5M TCGX Financing, Bluejay Deal Momentum, and a Fresh $140 Price Target

December 19, 2025 — Mirum Pharmaceuticals, Inc. is in the spotlight today after announcing additional financing tied to its planned Bluejay Therapeutics acquisition and drawing bullish analyst commentary that helped power a sharp move in the stock. As of the latest reported trade on Friday, December 19, 2025, MIRM was trading around $76.71, up about 9.15% from the prior close, after touching an intraday high near $77.19.
19 December 2025
·

Stock Market Today

  • Goldman Sachs Sees AI Sector Leverage at $1.4 Trillion as Rally Drives Risks
    July 1, 2026, 7:17 AM EDT. Goldman Sachs is flagging $1.4 trillion in leveraged bets across U.S. stocks, most of it in names tied to AI. The bank says margin debt now makes up 1.8% of U.S. equities and warns that this adds real risk if the market turns and triggers forced selling. Margin borrowing in Japan now tops $30 billion, the most since 2008. Big tech-the 'Magnificent Seven'-has lagged, pressured by crowding, cautious Fed signals and rising costs. Wells Fargo sees delayed AI IPOs as a bullish sign, pointing to stronger adoption trends that could lift demand and push the AI cycle further despite higher leverage.
Go toTop